MEDICOVER AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.8 SEK | +4.24% |
|
+3.91% | +31.11% |
| Apr. 29 | Nordic Shares Rose Monday; Ratos Series A Climbed Highest | DJ |
| Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
| Sales 2024 * | 2.03B 2.2B 23.2B | Sales 2025 * | 2.35B 2.55B 26.87B | Capitalization | 2.58B 2.8B 29.44B |
|---|---|---|---|---|---|
| Net income 2024 * | 26M 28.2M 297M | Net income 2025 * | 62M 67.24M 708M | EV / Sales 2024 * | 1.77 x |
| Net Debt 2024 * | 1.01B 1.09B 11.52B | Net Debt 2025 * | 1.11B 1.2B 12.64B | EV / Sales 2025 * | 1.57 x |
| P/E ratio 2024 * |
97.5
x | P/E ratio 2025 * |
41.7
x | Employees | 45,316 |
| Yield 2024 * |
0.7% | Yield 2025 * |
0.77% | Free-Float | 41.01% |
More Fundamentals
* Assessed data
More news
Latest transcript on Medicover AB
More news
| 1 day | +4.24% | ||
| 1 week | +3.91% | ||
| 1 month | +12.46% | ||
| 3 months | +38.11% | ||
| 6 months | +37.43% | ||
| Current year | +31.11% |
1 week
181.80
196.80
1 month
174.40199.00
Current year
129.20199.00
1 year
118.30199.00
3 years
109.90372.00
5 years
71.50372.00
10 years
57.25372.00
| Managers | Title | Age | Since |
|---|---|---|---|
Fredrik Rågmark
CEO | Chief Executive Officer | 61 | 94-12-31 |
Joe Ryan
DFI | Director of Finance/CFO | 59 | 95-12-31 |
| Chief Tech/Sci/R&D Officer | 73 | 17-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fredrik Rågmark
CEO | Chief Executive Officer | 61 | 94-12-31 |
| Director/Board Member | 84 | 06-12-31 | |
Arno Bohn
BRD | Director/Board Member | 77 | 00-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.11% | 5 M€ | +15.85% | ||
| 0.02% | 746 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 196.8 | +4.24% | 232,309 |
| 24-05-30 | 188.8 | +3.06% | 56,464 |
| 24-05-29 | 183.2 | -3.07% | 67,895 |
| 24-05-28 | 189 | -0.74% | 50,280 |
| 24-05-27 | 190.4 | +0.53% | 29,681 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotes
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicoverâs own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Calendar
2024-07-25
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
17.23
EUR
Average target price
17.01
EUR
Spread / Average Target
-1.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.11% | 2.8B | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -0.35% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +79.20% | 13.21B | |
| +70.11% | 13.08B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- MCOV B Stock
